Gambro continues expansion in Virginia
Gambro continues expansion in Virginia Stockholm, Sweden - Gambro AB (Stockholm Stock Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that its subsidiary Gambro Healthcare, Inc. has acquired Richmond's largest outpatient dialysis clinic - the Westwood Dialysis Center. The center, which was formerly owned by Bon Secours Memorial Regional Medical Center, Inc., provides outpatient services to 110 patients. With this acquisition, Gambro now serves over 700 patients in the Richmond area and maintains its position as the leading provider of renal care services in this community. "The Westwood Dialysis Center was selected as it paralleled our high standards for excellence in patient care and supports our strategy of selectively expanding our network of clinics," stated Mats Wahlström, President of Gambro Healthcare. "This acquisition strengthens our local position and is another step towards our goal of becoming the world's leading provider of high quality renal care services." Dialysis treatment and related patient services will continue to be under the supervision of the medical directors affiliated with Bon Secours Memorial Regional Center, Inc. Gambro Healthcare, Inc. is a wholly owned subsidiary of Gambro AB, a world- leading medical technology and healthcare company. Gambro Healthcare is a fully integrated service provider in renal replacement therapy. Its activities include risk contracting, disease management, physician practice management, dialysis services, and clinical laboratory services. Gambro Healthcare is the second largest provider of kidney dialysis services in the US. The company now owns, operates, manages or provides consulting services to 478 dialysis centers in the United States that serve about 35,200 patients. There are patients under treatment in centers across 33 states and the District of Columbia. Several of these centers are associated with prominent academic institutions. For further information please contact: Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8-613 65 00, +46-70-513 65 33 Anna Augustson, European Investor Relations Manager, tel. +46-8-613 65 35, +46-70-513 65 34 Tim Schoenberg, Vice President, US Investor Relations Manager, +1-949-425-2185 Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology (BCT). Gambro is the second largest provider of kidney dialysis services in the world. Gambro treats about 41,500 patients in 569 clinics worldwide. Renal care products comprise dialyzers, dialysis machines, blood lines and dialysis fluid. BCT includes products for the separation and handling of blood components. The group, with revenue of approximately SEK 19 billion (USD 2.3 billion) has approximately 18,000 employees in some 40 countries. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/05/06/19990506BIT00060/bit0001.doc http://www.bit.se/bitonline/1999/05/06/19990506BIT00060/bit0002.pdf